Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
Solidus Investment
SeoulSeed–Series A
8 people
Vertex Ventures China
SingaporePre-Seed–Series A
6 people
Decheng Capital
Menlo ParkSeed–Growth
14 people
iGlobe Partners
SingaporeSeed–Growth$600K – $6M
23 people
TMV
New YorkPre-Seed–Series A$1.5M
13 people
LIONHEART VENTURES
San FranciscoSeed–Growth
36 people
Blue Horizon Corporation
ZurichSeed–Growth
14 people
Bow Capital
Menlo ParkSeed–Series A$5M
11 people
Innova Memphis, Inc.
MemphisPre-Seed–Series A$2M
4 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Growth
29 people
Innovation Industries
AmsterdamSeed–Growth$2.2M – $54M
25 people
SODENA
PamplonaSeed–Series B$108K
41 people
AAF Management Ltd.
WashingtonPre-Seed–Series A
4 people
Kaiser Permanente Ventures
San FranciscoSeed–Growth$2M – $5M
13 people
iSelect Fund
St. LouisSeed–Series B$250K – $2M
10 people
Calculus Capital Ltd.
LondonSeed–Series A$2.5M
31 people
ClavystBio
SingaporeSeed–Series A
36 people
Kicker Ventures
San FranciscoPre-Seed–Series A$100K – $1M
30 people
Seneca Partners
HaydockSeed–Series A
11 people
Argonautic Ventures
New YorkPre-Seed–Growth$5M
11 people
DBL Partners
Palo AltoSeries A
10 people
Signal Peak Ventures
Salt Lake CityPre-Seed–Series B$250K – $5M
15 people
Oxford Investment Opportunity Network (OION)
OxfordSeed–Series A$190K – $2.5M
HCVC
ParisPre-Seed–Series A$100K – $1M
7 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Series A Investors & VC Firms in United States (3839)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2384)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2310)Enterprise Software Series A Investors & VC Firms (2265)
Data sourced from public filings and firms' own websites — see our methodology.


































































































